HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radim Havelek Selected Research

pancracine

6/2021Pancracine, a Montanine-Type Amaryllidaceae Alkaloid, Inhibits Proliferation of A549 Lung Adenocarcinoma Cells and Induces Apoptotic Cell Death in MOLT-4 Leukemic Cells.
1/2020Amaryllidaceae Alkaloids of Different Structural Types from Narcissus L. cv. Professor Einstein and Their Cytotoxic Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Radim Havelek Research Topics

Disease

23Neoplasms (Cancer)
10/2023 - 06/2011
4Breast Neoplasms (Breast Cancer)
01/2018 - 12/2013
3Adenocarcinoma of Lung
10/2023 - 01/2019
3Leukemia
08/2019 - 07/2012
2Glioblastoma (Glioblastoma Multiforme)
12/2023 - 06/2023
2Carcinoma (Carcinomatosis)
09/2023 - 11/2016
2Hypercholesterolemia
01/2022 - 01/2019
2Alzheimer Disease (Alzheimer's Disease)
05/2020 - 04/2019
2Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 11/2017
2Adenocarcinoma
11/2016 - 12/2013
1Ataxia Telangiectasia (Louis Bar Syndrome)
10/2022
1Hyperglycemia
01/2022
1Atherosclerosis
01/2019
1Inflammation (Inflammations)
01/2019
1Lymphoma (Lymphomas)
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
03/2016
1Triple Negative Breast Neoplasms
01/2016
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2012
1Lymphoid Leukemia
06/2011

Drug/Important Bio-Agent (IBA)

7AlkaloidsIBA
10/2023 - 06/2016
5Cisplatin (Platino)FDA LinkGeneric
09/2023 - 07/2012
4hemanthamineIBA
04/2019 - 03/2014
3montanineIBA
10/2023 - 01/2020
3LigandsIBA
08/2019 - 01/2019
3DNA (Deoxyribonucleic Acid)IBA
09/2018 - 06/2011
3Amaryllidaceae AlkaloidsIBA
09/2017 - 03/2014
2flubendazoleIBA
12/2023 - 06/2023
2Cytostatic AgentsIBA
10/2023 - 08/2019
2Phosphotransferases (Kinase)IBA
10/2022 - 01/2018
2EndoglinIBA
01/2022 - 01/2019
2Trypan BlueFDA Link
06/2021 - 01/2019
2pancracineIBA
06/2021 - 01/2020
2crinaneIBA
04/2019 - 03/2014
2Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2018
2CholesterolIBA
01/2019 - 12/2013
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2018 - 11/2016
2isoquinolineIBA
01/2018 - 06/2016
1manthineIBA
10/2023
1NAD (NADH)IBA
06/2022
1GraphiteIBA
06/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1carotuximabIBA
01/2022
1Mannitol (Osmitrol)FDA LinkGeneric
01/2022
1AcetylcholinesteraseIBA
05/2020
1Galantamine (Galanthamine)FDA LinkGeneric
05/2020
1MolybdenumIBA
08/2019
1ApolipoproteinsIBA
01/2019
1IgA receptor (protein B)IBA
01/2019
17-ketocholesterolIBA
01/2019
1P-SelectinIBA
01/2019
1Apolipoproteins E (ApoE)IBA
01/2019
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2019
1LDL Receptors (LDL Receptor)IBA
01/2019
1Mitogen-Activated Protein KinasesIBA
01/2019
1Cadherins (E-Cadherin)IBA
01/2019
1discretamine (scoulerine)IBA
01/2018
1Butyric Acid (Butanoic Acid)IBA
11/2017
1Histones (Histone)IBA
11/2017
1boldineIBA
11/2016
1chelidonineIBA
03/2016
1homochelidonineIBA
03/2016
1betulinIBA
01/2016
1hemanthidineIBA
03/2014
1TomatineIBA
12/2013
1vanadocene dichlorideIBA
07/2012

Therapy/Procedure

3Therapeutics
10/2022 - 01/2018
2Drug Therapy (Chemotherapy)
11/2017 - 07/2012
2Radiotherapy
10/2014 - 06/2011
1Injections
11/2016